Johnson & Johnson (JNJ) EBITDA Margin (QoQ) (2009 - 2026)
Johnson & Johnson (JNJ) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.73 Bn | 631.97 Bn | 17.26 Bn |
| 2 | AbbVie | 469.89 Bn | 463.32 Bn | 12.70 Bn |
| 3 | Merck | 377.61 Bn | 370.47 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.24 Bn | 295.55 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.81 Bn | 252.91 Bn | 12.86 Bn |
| 6 | Amgen | 237.20 Bn | 223.21 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.20 Bn | 179.02 Bn | 6.22 Bn |
| 8 | Pfizer | 159.71 Bn | 148.02 Bn | 10.94 Bn |
| 9 | Gsk | 106.41 Bn | 102.24 Bn | 8.24 Bn |
| 10 | Sanofi | 55.04 Bn | 47.66 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 177.00 |
| Mar 29, 2026 | 403.00 |
| Dec 28, 2025 | -689.00 |
| Sep 28, 2025 | 132.00 |
| Jun 29, 2025 | -25.00 |
| Mar 30, 2025 | 1,226.00 |
| Dec 29, 2024 | -643.00 |
| Sep 29, 2024 | -641.00 |
| Jun 30, 2024 | 119.00 |
| Mar 31, 2024 | 776.00 |
| Dec 31, 2023 | -701.00 |
| Oct 1, 2023 | -13.00 |
| Jul 2, 2023 | -34.00 |
| Apr 2, 2023 | -2,083.00 |
| Jan 1, 2023 | 2,169.00 |
| Oct 2, 2022 | 731.00 |
| Jul 3, 2022 | -275.00 |
| Oct 3, 2021 | 170.00 |
| Jul 4, 2021 | -294.00 |
| Apr 4, 2021 | -669.00 |